Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Continuous in vitro culture and genetics of Plasmodium vivax in a bespoke blood cell bioreactor

Award Number: R61AI187114
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/07/2025
PERIOD OF PERFORMANCE END DATE: 03/31/2028

Group Awards By:

View Award Description

Continuous in vitro culture and genetics of Plasmodium vivax in a bespoke blood cell bioreactor - Project Summary Malaria resulting from infection of humans with the parasite Plasmodium vivax parasite remains a significant public health problem. Significant gaps remain in our understanding of P. vivax blood- and transmission-stage biology, as well as the development of drug and vaccine interventions. When compared to that of Plasmodium falciparum, this knowledge lags substantially because of the lack of an in vitro culture system. Indeed, much of our undersatnding of P. vivax is based on limited studies in human and animal model systems. We hypothesize that mimicking physiologically-relevant conditions experienced by P. vivax will support continuous culture in reticulocytes, the youngest of red blood cells and the host cell of the parasite. Our long-term objective is to continuously culture P. vivax parasites. We will utilize a bioreactor to control the culture environment to facilitate P. vivax growth in in vivo-like conditions, including in co-cultures with stromal cells from the bone marrow and splenic niches. In parallel, we will draw upon our expertise in in vitro genetics for both RBCs in vitro and Plasmodium parasites: we will engineer stem cells capable of producing reticulocytes more susceptible to P. vivax infection and recombinant parasites with enhanced ability to invade red blood cells. We thus will focus on optimizing parasite and reticulocyte health, as well as host-parasite interactions. Our specific aims in the R61 period are to optimize P. vivax culture in a bespoke bioreactor wherein we will mimic the in vivo physiological conditions of parasite proliferates. This includes: (1) the efficientproduction of host reticulocytes to support P. vivax culture; (2) the optimization of culture conditions in a bespoke bioreactor using iterative machine learning approaches; and (3) the use of diverse P. vivax parasites. In the R33 period, we will develop genetic methods for P. vivax, and use these to conduct a genetic screen to understand and overcome the restriction of P. vivax to reticulocytes. 01/09/2024


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $371,484 )
2026	2026	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	1033 MASSACHUSETTS AVE STE 3	CAMBRIDGE	MA	02138	MIDDLESEX	USA	Allergy and Infectious Diseases Research	000	2	4/27/2026	NON-COMPETING CONTINUATION	$371,484
														Subtotal = $371,484

Issue Date FY: 2025 ( Subtotal = $406,450 )
2025	2025	HARVARD COLLEGE PRESIDENT & FELLOWS OF	677 HUNTINGTON AVE	BOSTON	MA	02115	SUFFOLK	USA	Allergy and Infectious Diseases Research	000	1	4/7/2025	NEW	$406,450
														Subtotal = $406,450

Grand Total All Awards = $777,934

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Continuous in vitro culture and genetics of Plasmodium vivax in a bespoke blood cell bioreactor

Award Number: R61AI187114

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/07/2025

PERIOD OF PERFORMANCE END DATE: 03/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer